Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 2
2001 1
2002 1
2003 2
2005 3
2006 1
2007 1
2008 3
2009 3
2010 5
2011 16
2012 9
2013 16
2014 18
2015 9
2016 18
2017 13
2018 6
2019 9
2020 13
2021 8
2022 9
2023 13
2024 17
2025 17

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

173 results

Results by year

Filters applied: . Clear all
Page 1
Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer.
Forde PM, Spicer J, Lu S, Provencio M, Mitsudomi T, Awad MM, Felip E, Broderick SR, Brahmer JR, Swanson SJ, Kerr K, Wang C, Ciuleanu TE, Saylors GB, Tanaka F, Ito H, Chen KN, Liberman M, Vokes EE, Taube JM, Dorange C, Cai J, Fiore J, Jarkowski A, Balli D, Sausen M, Pandya D, Calvet CY, Girard N; CheckMate 816 Investigators. Forde PM, et al. N Engl J Med. 2022 May 26;386(21):1973-1985. doi: 10.1056/NEJMoa2202170. Epub 2022 Apr 11. N Engl J Med. 2022. PMID: 35403841 Free PMC article. Clinical Trial.
Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer.
Forde PM, Spicer JD, Provencio M, Mitsudomi T, Awad MM, Wang C, Lu S, Felip E, Swanson SJ, Brahmer JR, Kerr K, Taube JM, Ciuleanu TE, Tanaka F, Saylors GB, Chen KN, Ito H, Liberman M, Martin C, Broderick S, Wang L, Cai J, Duong Q, Meadows-Shropshire S, Fiore J, Bhatia S, Girard N; CheckMate 816 Investigators. Forde PM, et al. N Engl J Med. 2025 Aug 21;393(8):741-752. doi: 10.1056/NEJMoa2502931. Epub 2025 Jun 2. N Engl J Med. 2025. PMID: 40454642 Clinical Trial.
Segmentectomy for ground-glass-dominant lung cancer with a tumour diameter of 3 cm or less including ground-glass opacity (JCOG1211): a multicentre, single-arm, confirmatory, phase 3 trial.
Aokage K, Suzuki K, Saji H, Wakabayashi M, Kataoka T, Sekino Y, Fukuda H, Endo M, Hattori A, Mimae T, Miyoshi T, Isaka M, Yoshioka H, Nakajima R, Nakagawa K, Okami J, Ito H, Kuroda H, Tsuboi M, Okumura N, Takahama M, Ohde Y, Aoki T, Tsutani Y, Okada M, Watanabe SI; Japan Clinical Oncology Group. Aokage K, et al. Among authors: ohde y. Lancet Respir Med. 2023 Jun;11(6):540-549. doi: 10.1016/S2213-2600(23)00041-3. Epub 2023 Mar 6. Lancet Respir Med. 2023. PMID: 36893780 Clinical Trial.
Neoadjuvant nivolumab plus chemotherapy in resectable non-small-cell lung cancer in Japanese patients from CheckMate 816.
Mitsudomi T, Ito H, Okada M, Sugawara S, Shio Y, Tomii K, Okami J, Sakakura N, Kubota K, Takamochi K, Atagi S, Tsuboi M, Oizumi S, Ikeda N, Ohde Y, Ntambwe I, Mahmood J, Cai J, Tanaka F. Mitsudomi T, et al. Among authors: ohde y. Cancer Sci. 2024 Feb;115(2):540-554. doi: 10.1111/cas.16030. Epub 2023 Dec 14. Cancer Sci. 2024. PMID: 38098261 Free PMC article. Clinical Trial.
Evaluation of whole genome sequencing utility in identifying driver alterations in cancer genome.
Nagashima T, Yamaguchi K, Urakami K, Shimoda Y, Ohnami S, Ohshima K, Tanabe T, Naruoka A, Kamada F, Serizawa M, Hatakeyama K, Ohnami S, Maruyama K, Mochizuki T, Mizuguchi M, Shiomi A, Ohde Y, Bando E, Sugiura T, Mukaigawa T, Nishimura S, Hirashima Y, Mitsuya K, Yoshikawa S, Kiyohara Y, Tsubosa Y, Katagiri H, Niwakawa M, Takahashi K, Kashiwagi H, Yasunaga Y, Ishida Y, Sugino T, Kenmotsu H, Terashima M, Takahashi M, Uesaka K, Akiyama Y. Nagashima T, et al. Among authors: ohde y. Sci Rep. 2024 Oct 12;14(1):23898. doi: 10.1038/s41598-024-74272-0. Sci Rep. 2024. PMID: 39396060 Free PMC article.
A phase 2 study of adjuvant chemotherapy with 5-fluorouracil/leucovorin and oxaliplatin after lung metastasectomy for colorectal cancer (WJOG5810G).
Machida N, Okumura T, Boku N, Kishimoto J, Nishina T, Suyama K, Ohde Y, Shinozaki K, Baba H, Tokunaga S, Kawakami H, Tsuda T, Kotaka M, Okuda H, Yasui H, Yamazaki K, Hironaka S, Muro K, Hyodo I. Machida N, et al. Among authors: ohde y. Cancer. 2025 Apr 1;131(7):e35807. doi: 10.1002/cncr.35807. Cancer. 2025. PMID: 40130723 Free PMC article. Clinical Trial.
Prognostic impact of PD-L1 expression in surgically resected EGFR-mutant lung adenocarcinoma: A real-world database study in Japan (CReGYT-01 EGFR study).
Nomura K, Takada K, Kinoshita F, Muto S, Matsubara T, Kouki Y, Katsumata S, Hamada A, Haratake N, Fujino K, Yoshikawa M, Suzawa K, Shien K, Suda K, Ohara S, Fukuda S, Suzuki H, Okamoto T, Hirai F, Aokage K, Shiono S, Soh J, Tsuboi M, Shimokawa M, Ohde Y. Nomura K, et al. Among authors: ohde y. Int J Cancer. 2025 Apr 1;156(7):1480-1491. doi: 10.1002/ijc.35270. Epub 2024 Nov 21. Int J Cancer. 2025. PMID: 39569608
Prognostic Impact of Postoperative Recurrence in Patients With Epidermal Growth Factor Receptor-Positive Non-Small Cell Lung Cancer.
Morita M, Ono A, Sekikawa M, Doshita K, Miura K, Kodama H, Yabe M, Morikawa N, Iida Y, Mamesaya N, Kobayashi H, Ko R, Wakuda K, Kenmotsu H, Naito T, Murakami H, Isaka M, Ohde Y, Takahashi T. Morita M, et al. Among authors: ohde y. Cancer Rep (Hoboken). 2024 Sep;7(9):e70004. doi: 10.1002/cnr2.70004. Cancer Rep (Hoboken). 2024. PMID: 39245880 Free PMC article.
Similar Trend in Benefit of Adjuvant Platinum in Lung Cancer Patients Irrespective of Epidermal Growth Factor Receptor Mutation Status.
Suda K, Fujino K, Yoshikawa M, Shien K, Suzawa K, Nomura K, Fukuda S, Ohara S, Hamada A, Kinoshita F, Hayasaka K, Notsuda H, Takamori S, Muto S, Katsumata S, Shimokawa M, Soh J, Tsutani Y; CReGYT-EGFR Study Group. Suda K, et al. Eur J Cardiothorac Surg. 2025 Jul 1;67(7):ezaf239. doi: 10.1093/ejcts/ezaf239. Eur J Cardiothorac Surg. 2025. PMID: 40690369
The effect of epidermal growth factor receptor mutation on adjuvant chemotherapy with tegafur/uracil for patients with completely resected, non-lymph node metastatic non-small cell lung cancer (> 2 cm): a multicenter, retrospective, observational study as exploratory analysis of the CSPOR-LC03 study.
Miyoshi T, Aokage K, Watanabe SI, Ito H, Sakakura N, Mun M, Yamashita M, Ohde Y, Aoki T, Nishio W, Taguri M, Tsuboi M. Miyoshi T, et al. Among authors: ohde y. Jpn J Clin Oncol. 2024 Nov 2;54(11):1185-1193. doi: 10.1093/jjco/hyae073. Jpn J Clin Oncol. 2024. PMID: 39255996 Free PMC article.
173 results